CR20110195A - Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas - Google Patents
Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianasInfo
- Publication number
- CR20110195A CR20110195A CR20110195A CR20110195A CR20110195A CR 20110195 A CR20110195 A CR 20110195A CR 20110195 A CR20110195 A CR 20110195A CR 20110195 A CR20110195 A CR 20110195A CR 20110195 A CR20110195 A CR 20110195A
- Authority
- CR
- Costa Rica
- Prior art keywords
- bacterial infections
- fusioned
- treatment
- heteroaromatic compounds
- spirocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Abstract
La presente invención se refiere a compuestos de la fórmula I, a sales farmacéuticamente aceptables de estos, a métodos de utilización de estos para tratar infecciones bacterianas y métodos para su preparación.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10518908P | 2008-10-14 | 2008-10-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20110195A true CR20110195A (es) | 2011-06-08 |
Family
ID=41668347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20110195A CR20110195A (es) | 2008-10-14 | 2011-04-14 | Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas |
Country Status (24)
Country | Link |
---|---|
US (1) | US8658641B2 (es) |
EP (1) | EP2350077B1 (es) |
JP (2) | JP5749169B2 (es) |
KR (1) | KR101676886B1 (es) |
CN (2) | CN104086565A (es) |
AR (1) | AR073862A1 (es) |
AU (1) | AU2009305203B2 (es) |
BR (1) | BRPI0920180B1 (es) |
CA (1) | CA2736335C (es) |
CL (1) | CL2011000838A1 (es) |
CO (1) | CO6382126A2 (es) |
CR (1) | CR20110195A (es) |
CU (1) | CU20110083A7 (es) |
DO (1) | DOP2011000102A (es) |
EA (1) | EA201100613A1 (es) |
EC (1) | ECSP11010980A (es) |
ES (1) | ES2565611T3 (es) |
HK (2) | HK1160127A1 (es) |
IL (1) | IL211728A0 (es) |
MX (1) | MX2011003598A (es) |
TW (1) | TW201020258A (es) |
UY (1) | UY32174A (es) |
WO (1) | WO2010043893A1 (es) |
ZA (1) | ZA201103533B (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9040528B2 (en) | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
EA201100613A1 (ru) * | 2008-10-14 | 2011-12-30 | Астразенека Аб | Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций |
EP2653464B1 (en) | 2012-04-20 | 2017-09-27 | Rohm and Haas Company | Benzylamine hydrophobe |
AU2013305879B2 (en) | 2012-08-21 | 2017-10-12 | Saladax Biomedical Inc. | Antibodies to aripiprazole and use thereof |
CA2882615C (en) | 2012-08-21 | 2019-07-09 | Ortho-Clinical Diagnostics, Inc. | Antibodies to quetiapine and use thereof |
PL2888234T3 (pl) | 2012-08-21 | 2018-07-31 | Janssen Pharmaceutica Nv | Hapteny arypiprazolu i ich zastosowanie w testach immunologicznych |
PT2888257T (pt) | 2012-08-21 | 2017-11-14 | Janssen Pharmaceutica Nv | Haptenos de quetiapina para utilização em ensaios imunológicos |
CA2882594C (en) | 2012-08-21 | 2019-07-16 | Ortho-Clinical Diagnostics, Inc. | Antibodies to risperidone and use thereof |
EP2888590B1 (en) | 2012-08-21 | 2020-07-08 | Janssen Pharmaceutica NV | Antibodies to olanzapine and use thereof |
WO2014031603A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to paliperidone haptens and use thereof |
ES2971506T3 (es) | 2012-08-21 | 2024-06-05 | Janssen Pharmaceutica Nv | Haptenos de paliperidona |
EP3492473A1 (en) | 2012-08-21 | 2019-06-05 | Janssen Pharmaceutica NV | Haptens of olanzipine |
AU2013305884B2 (en) | 2012-08-21 | 2017-10-05 | Saladax Biomedical Inc. | Antibodies to risperidone haptens and use thereof |
CN104736561B (zh) | 2012-08-21 | 2018-06-12 | 詹森药业有限公司 | 帕潘立酮的抗体及其用途 |
TR201809424T4 (tr) | 2012-08-21 | 2018-07-23 | Janssen Pharmaceutica Nv | Risperidon ve paliperidon haptenleri. |
JP6389177B2 (ja) | 2012-08-21 | 2018-09-12 | ヤンセン ファーマシューティカ エヌ.ベー. | オランザピンハプテンに対する抗体及びその使用 |
PL3385284T3 (pl) | 2012-08-21 | 2020-09-21 | Janssen Pharmaceutica Nv | Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie |
CA2882492C (en) | 2012-08-21 | 2019-05-28 | Ortho-Clinical Diagnostics, Inc. | Antibodies to aripiprazole haptens and use thereof |
CN102911188B (zh) * | 2012-08-22 | 2015-01-07 | 中国科学院南海海洋研究所 | 含硫双吲哚二酮哌嗪类化合物及其在制备抗肿瘤药物中的应用 |
US8889671B2 (en) | 2013-01-23 | 2014-11-18 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
KR20170007818A (ko) | 2014-05-29 | 2017-01-20 | 엔타시스 테라퓨틱스 리미티드 | 박테리아 감염의 치료를 위한 융합된,스피로환식 헤테로방향족 화합물 |
JP6540971B2 (ja) * | 2014-08-25 | 2019-07-10 | 日産化学株式会社 | Socパターン上でのパターン反転のための被覆用組成物 |
EP3215510B1 (en) | 2014-11-06 | 2023-06-07 | Bial-R&D Investments, S.A. | Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders |
FI3215511T3 (fi) | 2014-11-06 | 2024-05-16 | Bial R&D Invest S A | Substituoituja pyratsolo(1,5-a)pyrimidiinejä ja niiden käyttö lääketieteellisten häiriöiden hoitamisessa |
WO2016073891A1 (en) | 2014-11-06 | 2016-05-12 | Lysosomal Therapeutics Inc. | Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders |
SG11201708622UA (en) | 2015-02-02 | 2017-11-29 | Forma Therapeutics Inc | 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors |
WO2016126726A1 (en) | 2015-02-02 | 2016-08-11 | Forma Therapeutics, Inc. | Bicyclic [4,6,0] hydroxamic acids as hdac6 inhibitors |
WO2016168598A1 (en) | 2015-04-17 | 2016-10-20 | Forma Therapeutics, Inc. | 3-spirocyclic-6-hydroxamic acid tetralins as hdac inhibitors |
WO2017024455A1 (zh) * | 2015-08-07 | 2017-02-16 | 苏州大学张家港工业技术研究院 | 一种螺环羟吲哚咪唑啉并氧氮杂卓化合物及其合成方法 |
CN105152962B (zh) * | 2015-09-30 | 2017-06-16 | 淄博亿丰高分子材料科技股份有限公司 | N‑异丙基羟胺的制备方法 |
EP3390455A1 (en) | 2015-12-17 | 2018-10-24 | Janssen Pharmaceutica NV | Antibodies to quetiapine and use thereof |
CA3008809A1 (en) | 2015-12-17 | 2017-06-22 | Janssen Pharmaceutica Nv | Antibodies to risperidone and use thereof |
WO2017176961A1 (en) | 2016-04-06 | 2017-10-12 | Lysosomal Therapeutics Inc. | Imidazo [1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders |
KR20180133461A (ko) | 2016-04-06 | 2018-12-14 | 리소소말 테라퓨틱스 인크. | 피라졸로[1,5-a]피리미디닐 카르복스아미드 화합물 및 의학적 장애의 치료에서의 그의 용도 |
CA3020310A1 (en) | 2016-04-06 | 2017-10-12 | Lysosomal Therapeutics Inc. | Pyrrolo[1,2-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders |
AU2017261291C1 (en) * | 2016-05-05 | 2022-05-26 | Bial - R&D Investments, S.A. | Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders |
WO2017192931A1 (en) | 2016-05-05 | 2017-11-09 | Lysosomal Therapeutics Inc. | SUBSTITUTED IMDAZO[1,2-α]PYRIDINES, SUBSTITUTED IMIDAZO[1,2-α]PYRAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS |
EP3472131B1 (en) | 2016-06-17 | 2020-02-19 | Forma Therapeutics, Inc. | 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors |
CN109111465B (zh) * | 2017-06-22 | 2021-01-12 | 中国科学院上海药物研究所 | 噻唑烷酮螺嘧啶三酮类化合物及制备方法和用途 |
CN107827887B (zh) * | 2017-11-21 | 2019-01-08 | 上海博栋化学科技有限公司 | 具有抗细菌活性的三氮唑甲酯链接螺环类化合物及其制备方法和应用 |
US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
CN111925370B (zh) * | 2020-09-01 | 2023-07-21 | 湖北科苑生物药业有限公司 | 一种吡嗪并吡唑并萘啶类化合物及其制备方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU198036B (en) * | 1983-08-22 | 1989-07-28 | Hoechst Roussel Pharma | Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them |
US7208490B2 (en) * | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
US7371757B2 (en) * | 2003-08-15 | 2008-05-13 | Astrazeneca Ab | Fused heterocycles as inhibitors of glutamate racemase(MURI) |
EP1888597A2 (en) * | 2005-05-09 | 2008-02-20 | Warner-Lambert Company LLC | Antibacterial agents |
DOP2006000268A (es) * | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
EA201100613A1 (ru) * | 2008-10-14 | 2011-12-30 | Астразенека Аб | Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций |
-
2009
- 2009-10-13 EA EA201100613A patent/EA201100613A1/ru unknown
- 2009-10-13 CA CA2736335A patent/CA2736335C/en active Active
- 2009-10-13 CN CN201410168990.XA patent/CN104086565A/zh active Pending
- 2009-10-13 ES ES09736649.6T patent/ES2565611T3/es active Active
- 2009-10-13 JP JP2011531566A patent/JP5749169B2/ja active Active
- 2009-10-13 BR BRPI0920180-7A patent/BRPI0920180B1/pt active IP Right Grant
- 2009-10-13 US US13/124,889 patent/US8658641B2/en active Active
- 2009-10-13 CN CN200980151645.2A patent/CN102245605B/zh active Active
- 2009-10-13 MX MX2011003598A patent/MX2011003598A/es active IP Right Grant
- 2009-10-13 UY UY0001032174A patent/UY32174A/es not_active Application Discontinuation
- 2009-10-13 TW TW098134680A patent/TW201020258A/zh unknown
- 2009-10-13 WO PCT/GB2009/051363 patent/WO2010043893A1/en active Application Filing
- 2009-10-13 EP EP09736649.6A patent/EP2350077B1/en active Active
- 2009-10-13 AU AU2009305203A patent/AU2009305203B2/en active Active
- 2009-10-13 KR KR1020117008436A patent/KR101676886B1/ko active IP Right Grant
- 2009-10-14 AR ARP090103949A patent/AR073862A1/es unknown
-
2011
- 2011-03-14 IL IL211728A patent/IL211728A0/en unknown
- 2011-04-07 CO CO11043260A patent/CO6382126A2/es not_active Application Discontinuation
- 2011-04-14 CU CU2011000083A patent/CU20110083A7/es unknown
- 2011-04-14 DO DO2011000102A patent/DOP2011000102A/es unknown
- 2011-04-14 CL CL2011000838A patent/CL2011000838A1/es unknown
- 2011-04-14 CR CR20110195A patent/CR20110195A/es not_active Application Discontinuation
- 2011-04-14 EC EC2011010980A patent/ECSP11010980A/es unknown
- 2011-05-13 ZA ZA2011/03533A patent/ZA201103533B/en unknown
-
2012
- 2012-01-18 HK HK12100604.4A patent/HK1160127A1/zh unknown
-
2015
- 2015-03-24 HK HK15102962.3A patent/HK1203483A1/xx unknown
- 2015-05-11 JP JP2015096368A patent/JP2015178510A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20110195A (es) | Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas | |
EA201100447A1 (ru) | Органические соединения | |
ECSP10010582A (es) | Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer | |
EA201290191A1 (ru) | N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ | |
EA201170772A1 (ru) | Органические соединения | |
EA201391568A1 (ru) | Новые производные имидазола, подходящие для лечения артрита | |
CL2015001667A1 (es) | Derivados de manosa para tratar infecciones bacterianas. | |
EA201100503A1 (ru) | Глюкозидные производные и их применения | |
EA201291220A1 (ru) | Производные аминопиримидина в качестве модуляторов lrrk2 | |
UA111161C2 (uk) | Похідна фталазинонкетону, спосіб її одержання та її фармацевтичне застосування | |
EA201201648A1 (ru) | Стимуляторы sgc | |
EA201390274A1 (ru) | Борсодержащие малые молекулы | |
CL2009000426A1 (es) | Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas | |
EA201491149A1 (ru) | Пиразолопиридиновые производные, способы их получения и их терапевтическое применение | |
BR112012019762A2 (pt) | composto, composição, e, método para tratar uma doença. | |
CR11684A (es) | Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa | |
EA201500182A1 (ru) | 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ | |
BR112012012903A2 (pt) | compostos de espiropiperidina | |
UY31803A (es) | Compuesto cristalino | |
CL2014001154A1 (es) | Compuestos derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo de formula i; composicion farmaceutica; uso para la prevencion o tratamiento de una infeccion bacteriana. | |
EA201200098A1 (ru) | Конденсированные имидазолы и содержащие их композиции, предназначенные для лечения паразитарных заболеваний, таких как, например, малярия | |
ECSP13012494A (es) | Inhibidores de oxadiazol de la producción de leucotrieno. | |
MA32723B1 (fr) | Derives d'anilino-pyrimidine a substitution sulfoximine en tant qu'inhibiteurs de cdk, leur preparation et leur utilisation comme medicaments | |
EA201490438A1 (ru) | Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные циклопента[c]пирролом | |
EA201190293A1 (ru) | Пролекарства триптолида |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |